FDA Inspection 1257817 — Ashish T. Nikhare, MBBS
The FDA completed an inspection of Ashish T. Nikhare, MBBS on Dec 4, 2024 in Nagpur. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 4, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nagpur (India)
Additional details
Clinical BA/BE